Cart
sales@molnova.com
DC260126
CAS No. 346692-04-4
DC260126( —— )
Catalog No. M20675 CAS No. 346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 137 | In Stock |
|
| 50MG | 211 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDC260126
-
NoteResearch use only, not for human use.
-
Brief DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40).
-
DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40) .
-
In VitroDC260126 reduces GTP-loading and ERK1/2 phosphorylation stimulated by linoleic acid in GPR40-CHO cells, suppresses palmitic acid potentiated glucose-stimulated insulin secretion, and negatively regulates GPR40 mRNA expression induced by oleic acid in Min6 cells.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR40
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number346692-04-4
-
Formula Weight307.38
-
Molecular FormulaC16H18FNO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (325.33 mM)
-
SMILESCCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng S Ting W Yuren Z et al. DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice[J]. PLoS ONE 2013 8(6):e66744-.
molnova catalog
related products
-
3-chloro-5-hydroxybe...
3-chloro-5-hydroxy Benzoic Acid (3-chloro-5-hydroxy BA) is an agonist of GPR81 (EC50 : 16 μM).
-
Acifran
Acifran (AY 25712) is an HM74A/GPR109A and GPR109B agonist and displays antihyperlipidemic activity.
-
GPR81 agonist 1
GPR81 agonist 1 is a potent and selective GPR81 agonist with high affinity for human and mouse GPR81, inhibiting lipolysis of differentiated 3T3-L1 adipocytes, improving insulin sensitivity and glycaemic control in mouse models of insulin resistance and diabetes, and can be used in the study of diabetes and obesity.
